Reported 3 days ago
23andMe's stock plummeted by 59% following its filing for Chapter 11 bankruptcy and the resignation of CEO Anne Wojcicki. The company, once a leader in DNA testing with 15 million consumers, has faced significant challenges including a recent data privacy breach and internal board conflicts. Following failed acquisition efforts and a court petition for structured asset sales, Wojcicki expressed her disappointment at the board's rejection of her bid to take the company private.
Source: YAHOO